RELATIVE DOSING OF PHOSPHATE BINDERS FOR EFFECTIVE MANAGEMENT OF PHOSPHATE AND PROTEIN INTAKE IN CHRONIC KIDNEY DISEASE
Patients with chronic kidney disease undergoing haemodialysis have a maximum recommended dietary phosphate (P) intake of 1000 mg/day and a recommended protein intake of 1.2 g/kg/day. Achieving this level of protein intake is associated with the best patient outcomes. However, protein-containing food...
Main Authors: | J Brian Copley, Jamie Heise |
---|---|
Format: | Article |
Language: | English |
Published: |
The Korean Society of Nephrology
2012-06-01
|
Series: | Kidney Research and Clinical Practice |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2211913212006560 |
Similar Items
-
PHOSPHATE BINDER THERAPY AND SERUM PHOSPHATE CONTROL FOLLOWING INITIATION OF HAEMODIALYSIS
by: Kimberly Farrand, et al.
Published: (2012-06-01) -
Phosphate binders in chronic kidney disease: The positions of sevelamer
by: V V Fomin, et al.
Published: (2013-06-01) -
Analysis of serum phosphate control and phosphate binder utilization in incident hemodialysis patients
by: Farr, et al.
Published: (2014-07-01) -
Sevelamer versus calcium-based phosphate binders for chronic kidney disease
by: Gonzalo A Bravo-Soto
Published: (2017-06-01) -
Phosphate binders for the treatment of chronic kidney disease: role of iron oxyhydroxide
by: Cernaro V, et al.
Published: (2016-02-01)